Global Product Portfolio
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit and to learn about our generics and radiopharmaceutical products. Please note: Not all treatments are available in all countries.
lapatinib
Tyverb®
(lapatinib)OncologyOncology
letrozole
Femara®
(letrozole)OncologyOncology
lutetium Lu 177 dotatate
Lutathera®
(lutetium Lu 177 dotatate)Advanced Accelerator Applications
methylphenidate HCl
Ritalin®
(methylphenidate HCl)NeuroscienceEstablished MedicinesAvailable in:
methylphenidate HCl modified release
Ritalin LA®
(methylphenidate HCl modified release)NeuroscienceEstablished Medicines
midostaurin
Rydapt®
(midostaurin)OncologyOncology